{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:01:41Z","timestamp":1774882901437,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan\u2019s Ministry of Science and Technology","doi-asserted-by":"crossref","award":["MOST 107-2314-B-039-065-MY3"],"award-info":[{"award-number":["MOST 107-2314-B-039-065-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU107-Z-04"],"award-info":[{"award-number":["CMU107-Z-04"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate medication adherence among patients with hepatitis B-related cirrhosis who developed decompensation and mortality, and to examine the association between medication adherence and patients\u2019 disease outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>In this retrospective case\u2013control study, patients aged over 20 years old and diagnosed with both chronic hepatitis B and cirrhosis from 2007 to 2016 are identified using a population-based medical claims database. Two prognosis endpoints (decompensation and mortality) are used, respectively, to classify subjects into two different case\u2013control sets. Study groups are propensity-score matched. Medication possession ratio (MPR) is used as a measure of treatment adherence for oral antiviral drugs, and conditional logistic regression models are used to estimate the odds of decompensation and mortality after accounting for MPR and other covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between decompensated and compensated patients, longer term treatment adherence is seen higher in the compensated group versus the decompensated group: 1-year MPR (0.65\u00b10.43 vs 0.57\u00b10.53) and 6-month MPR (0.79\u00b10.52 vs 0.76\u00b10.79). On the contrary, 3-month adherence is higher in the decompensated group (1.00\u00b11.15 vs 0.96\u00b10.79). For patients with and without mortality, drug adherence is ubiquitously higher in the alive group regardless of follow-up length: 1-year MPR (0.62\u00b10.44 vs 0.50\u00b10.51), 6-month MPR (0.78\u00b10.62 vs 0.69\u00b10.72) and 3-month MPR (0.97\u00b10.91 vs 0.96\u00b11.12). After accounting for confounding variables, we find that the likelihood of complicated cirrhosis is significantly lower in more adherent patients and the benefit increases with more persistent adherence (log 1-year MPR OR: 0.75, 95%\u2009CI: 0.73 to 0.77). Similar results are observed for the adjusted likelihood of mortality (log 1-year MPR OR: 0.70, 95%\u2009CI: 0.68 to 0.72).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Long-term patient adherence to oral antiviral therapy remains inadequate in patients with hepatitis B virus-related cirrhosis. Their adherence to oral antiviral therapy appears to be inversely associated with decompensation and mortality.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2021-059856","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T15:33:05Z","timestamp":1655134385000},"page":"e059856","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case\u2013control study"],"prefix":"10.1136","volume":"12","author":[{"given":"Kuo-Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Lun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jou-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-0897","authenticated-orcid":false,"given":"Vivian Chia-Rong","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2022061308300865000_12.6.e059856.1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.pec.2018.01.022","article-title":"Pharmacist-nurse collaborations in medication adherence-enhancing interventions: a review","volume":"101","author":"Celio","year":"2018","journal-title":"Patient Educ Couns"},{"key":"2022061308300865000_12.6.e059856.2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2022061308300865000_12.6.e059856.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"2022061308300865000_12.6.e059856.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"2022061308300865000_12.6.e059856.5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jceh.2017.06.001","article-title":"Natural history of cirrhosis of liver after first decompensation: a prospective study in India","volume":"8","author":"Shah","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"2022061308300865000_12.6.e059856.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.019"},{"key":"2022061308300865000_12.6.e059856.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.033"},{"key":"2022061308300865000_12.6.e059856.8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.advms.2016.11.009","article-title":"Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment","volume":"62","author":"Piotrowski","year":"2017","journal-title":"Adv Med Sci"},{"key":"2022061308300865000_12.6.e059856.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080633"},{"key":"2022061308300865000_12.6.e059856.10","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.3748\/wjg.v23.i40.7321","article-title":"Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis","volume":"23","author":"Hayward","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2022061308300865000_12.6.e059856.11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jvh.12582","article-title":"Factors associated with poor adherence to antiviral treatment for hepatitis B","volume":"24","author":"Allard","year":"2017","journal-title":"J Viral Hepat"},{"key":"2022061308300865000_12.6.e059856.12","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2018.1433987","article-title":"Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B","volume":"11","author":"Xu","year":"2018","journal-title":"Glob Health Action"},{"key":"2022061308300865000_12.6.e059856.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-01219-w","article-title":"Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes","volume":"20","author":"Allard","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"2022061308300865000_12.6.e059856.14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13291","article-title":"Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs)","volume":"37 Suppl 1","author":"Grossi","year":"2017","journal-title":"Liver Int"},{"key":"2022061308300865000_12.6.e059856.15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1665-2681(19)31000-2","article-title":"Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review","volume":"12","author":"Lieveld","year":"2013","journal-title":"Ann Hepatol"},{"key":"2022061308300865000_12.6.e059856.16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cgh.2018.09.041","article-title":"Long-Term effects of treatment for chronic HBV infection on patient-reported outcomes","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022061308300865000_12.6.e059856.17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/liv.13253","article-title":"Four-Year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients","volume":"36","author":"Su","year":"2016","journal-title":"Liver Int"},{"key":"2022061308300865000_12.6.e059856.18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41395-018-0093-9","article-title":"Medication nonadherence increases hepatocellular carcinoma, cirrhotic complications, and mortality in chronic hepatitis B patients treated with entecavir","volume":"113","author":"Shin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2022061308300865000_12.6.e059856.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01494.x"},{"key":"2022061308300865000_12.6.e059856.20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.dld.2015.03.024","article-title":"Real life adherence of chronic hepatitis B patients to entecavir treatment","volume":"47","author":"van Vlerken","year":"2015","journal-title":"Dig Liver Dis"},{"key":"2022061308300865000_12.6.e059856.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00076-3"},{"key":"2022061308300865000_12.6.e059856.22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.clinre.2019.02.010","article-title":"Population-Based study of entecavir and long-term mortality in chronic hepatitis B-related decompensated liver cirrhosis","volume":"43","author":"Hung","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2022061308300865000_12.6.e059856.23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MCG.0000000000001192","article-title":"Gender differences among patients hospitalized with cirrhosis in the United States","volume":"54","author":"Rubin","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"2022061308300865000_12.6.e059856.24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jfma.2018.11.008","article-title":"Taiwan consensus statement on the management of chronic hepatitis B","volume":"118","author":"Chien","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"2022061308300865000_12.6.e059856.25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0290"},{"key":"2022061308300865000_12.6.e059856.26","first-page":"e498","article-title":"Medication adherence and readmission after myocardial infarction in the Medicare population","volume":"20","author":"Zhang","year":"2014","journal-title":"Am J Manag Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-059856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T15:33:22Z","timestamp":1655134402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-059856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2021-059856"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-059856","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}